CD34 and neoplasm: In summary, our data demonstrate the critical role of Mettl3 in driving BCa progression, as featured by expediting angiogenesis surrounding tumor cells, and unveil a previously unrecognized signaling axis involving Mettl3-TEK-VEGF-A-CD31/CD34 in bladder malignancy.